Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health


Personal tools

You are here: Home / Biomarkers / Zhong 5-antibody panel for Lung Cancer

Zhong 5-antibody panel for Lung Cancer



QA State: Curated
Short Name:
HGNC Name:

A potential autoantibody profile was developed to screen for non-small cell lung cancer. 212 immunogenic phage-expressed proteins were statistically ranked for their individual reactivity with 23 stage I cancer patient and 23 risk-matched control samples. Measurements of the five most predictive antibody markers in 46 cases and controls were combined. While the identity of these phage-expressed proteins is not critical for use in a diagnostic assay, the identities were determined through a nucleotide search of GenBank. Markers are: paxillin, SEC 15L2, BAC clone RP11-499F19, XRCC5, and MALAT1.

Panel Details


There are no datasets associated with this biomarker.


The following organs have data associated with this biomarker…



Phase: Two
QA State: Curated


Antibody profiling may be a useful tool for early detection of NSCLC.


This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at if you should have access to this biomarker.


No associated resources found.

2015 Steering Committee Meeting

The next EDRN Steering Committee Meeting will take place March 31st through April 2nd, 2015, in Atlanta, Georgia.

Announcement 02/12/2015

Please register for the 29th EDRN Steering Committee Meeting in Atlanta, GA from March 31-April 2, 2015. The registration page has information about booking hotel rooms and a draft agenda of the meeting.